Las Vegas, NV -- (SBWIRE) -- 10/07/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: ChemoCentryx Inc (NASDAQ:CCXI), Suntech Power Holdings Co., Ltd. (ADR) (NYSE:STP), Aastrom Biosciences Inc (NASDAQ:ASTM), Unilife Corp (NASDAQ:UNIS).
ChemoCentryx Inc (NASDAQ:CCXI) managed to keep its fall at -1.10% on traded volume of 1.89 million shares. The stock settled at $5.41 after floating in a range of $5.40 to $5.51. After recent close, it has reached market capitalization of $231.74 million. Its 52-week range has been $5.28 to $14.96. ChemoCentryx, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders, and cancer in the United States.
Will CCXI Get Buyers Even After The Recent Rally? Find Out Here
Suntech Power Holdings Co., Ltd. (ADR) (NYSE:STP) traded down on a volume of 1.88 million, lower than its standard daily volume. Shares have dropped -0.62% to $1.59. Over the last twelve months the stock has added 67.37% and faced a worst price of $1.56. Suntech Power Holdings Co., Ltd., a solar energy company, engages in the design, development, manufacture, and marketing of photovoltaic (PV) products.
Will STP Get Buyers Even After The Recent Rally? Find Out Here
Aastrom Biosciences Inc (NASDAQ:ASTM) settled -2.14% lower at $0.274 on traded volume of 1.81 million shares during the last trading day, while its average trading volume remained 1.30 million shares. The stock has its 12-month low at $0.27 and 52-week high price was $1.63. It traded in a range of $0.27 to $0.29 during the last trading day. Aastrom Biosciences, Inc., a development stage company, engages in the development of patient-specific, cell products for use in the treatment of severe, chronic ischemic cardiovascular diseases.
Will ASTM Get Buyers Even After The Recent Rally? Find Out Here
Unilife Corp (NASDAQ:UNIS) saw its price gain on traded volume as 1.74 million shares changed hands when compared with its average daily volume of 1.31 million shares. The stock was up 3.09% to $3.34. It has gained over the last 12 months, increasing 14.38% and marked new low $1.80. Unilife Corporation designs, develops, manufactures, and commercializes inject able drug delivery systems in the United States and internationally.
Will UNIS Continue To Move Higher? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)